𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mitoxantrone: beneficial first- and second-line treatment for breast cancer

Book ID
120859858
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2003
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mitoxantrone as a first-line treatment o
Mitoxantrone as a first-line treatment of advanced breast cancer
✍ Karl Landys; Stig Borgstrom; Torsten Andersson; Henry Noppa πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 354 KB

Forty-two Women with measurable or evaluable advanced breast cancer who had received neither prior chemotherapy for advanced disease nor any anthracycline-containing regimen as adjuvant were entered in a phase II study of mitoxantrone (Novantrone| dihydroxyanthracenedione). Patients were aged from 3

First-line combination chemotherapy with
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer
✍ P. Periti; G. Robustelli Delia Cuna; F. Pannuti; T. Mazzei; P. Preti; A. Martoni πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 312 KB

In this study, 30 evaluable patients with advanced carcinoma of the breast were treated with cyclophosphamide 600 mg/m2 i.v. followed one day later with mitoxantrone (Novantrone; dihydroxyanthracenedione) 16 mg/m2 i.v. Drug treatment was repeated every 3-4 weeks, for a maximum of 12 cycles. The over